Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 1 | 81 | 2024 | 3447 | 10.030 |
Why?
|
Islets of Langerhans Transplantation | 34 | 2024 | 748 | 6.760 |
Why?
|
Diabetic Nephropathies | 21 | 2023 | 973 | 3.260 |
Why?
|
Insulin-Secreting Cells | 14 | 2024 | 899 | 3.210 |
Why?
|
Pancreas Transplantation | 25 | 2011 | 193 | 2.940 |
Why?
|
Diabetes Mellitus, Type 2 | 30 | 2024 | 12253 | 2.450 |
Why?
|
Hypoglycemic Agents | 18 | 2023 | 3110 | 2.440 |
Why?
|
Graft Rejection | 21 | 2022 | 4492 | 2.180 |
Why?
|
Receptors, Purinergic P2X7 | 5 | 2018 | 86 | 2.120 |
Why?
|
Kidney Transplantation | 35 | 2024 | 4265 | 2.070 |
Why?
|
Islets of Langerhans | 12 | 2024 | 1351 | 1.890 |
Why?
|
Adenosine Triphosphate | 9 | 2023 | 2003 | 1.860 |
Why?
|
Blood Glucose | 23 | 2024 | 6435 | 1.710 |
Why?
|
Diabetes Mellitus, Experimental | 11 | 2023 | 1124 | 1.500 |
Why?
|
Stem Cells | 11 | 2022 | 3539 | 1.490 |
Why?
|
Graft Survival | 30 | 2024 | 3888 | 1.460 |
Why?
|
Hyperglycemia | 7 | 2024 | 1389 | 1.420 |
Why?
|
Autoimmunity | 10 | 2021 | 1360 | 1.420 |
Why?
|
Glucagon-Like Peptides | 2 | 2023 | 157 | 1.410 |
Why?
|
Blood Glucose Self-Monitoring | 6 | 2023 | 475 | 1.370 |
Why?
|
Kidney Failure, Chronic | 18 | 2022 | 2493 | 1.260 |
Why?
|
Diabetes Mellitus | 13 | 2024 | 5892 | 1.220 |
Why?
|
Podocytes | 5 | 2023 | 403 | 1.210 |
Why?
|
Uremia | 9 | 2011 | 202 | 1.200 |
Why?
|
Heart Transplantation | 14 | 2024 | 3301 | 1.120 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 2 | 2022 | 416 | 1.120 |
Why?
|
Autoimmune Diseases | 5 | 2023 | 2258 | 1.100 |
Why?
|
Hematopoietic Stem Cells | 6 | 2022 | 3408 | 1.070 |
Why?
|
Cytokines | 19 | 2024 | 7453 | 1.050 |
Why?
|
Mice, Inbred NOD | 17 | 2023 | 1839 | 1.010 |
Why?
|
Stem Cell Transplantation | 4 | 2017 | 1602 | 0.990 |
Why?
|
Purinergic P2X Receptor Antagonists | 3 | 2014 | 24 | 0.970 |
Why?
|
Insulinoma | 3 | 2024 | 122 | 0.960 |
Why?
|
Hematopoietic Stem Cell Transplantation | 8 | 2022 | 5716 | 0.930 |
Why?
|
Mice, Inbred C57BL | 32 | 2024 | 22379 | 0.840 |
Why?
|
Interleukin-8 | 3 | 2021 | 705 | 0.820 |
Why?
|
Blood Coagulation Disorders | 2 | 2022 | 350 | 0.820 |
Why?
|
Mice, Inbred BALB C | 22 | 2024 | 6232 | 0.810 |
Why?
|
Glucosides | 2 | 2023 | 533 | 0.780 |
Why?
|
Animals | 87 | 2024 | 169335 | 0.770 |
Why?
|
Humans | 181 | 2024 | 768970 | 0.760 |
Why?
|
Weight Loss | 4 | 2021 | 2721 | 0.760 |
Why?
|
Transplantation, Homologous | 19 | 2023 | 4835 | 0.760 |
Why?
|
Mesenchymal Stem Cell Transplantation | 6 | 2015 | 507 | 0.750 |
Why?
|
Receptors, CXCR | 1 | 2021 | 52 | 0.740 |
Why?
|
Insulin | 17 | 2023 | 6610 | 0.730 |
Why?
|
Peritoneal Dialysis | 1 | 2022 | 160 | 0.720 |
Why?
|
Th2 Cells | 2 | 2018 | 1079 | 0.720 |
Why?
|
Receptors, CXCR4 | 3 | 2016 | 729 | 0.700 |
Why?
|
Mice | 61 | 2024 | 82072 | 0.690 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2021 | 113 | 0.690 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2020 | 93 | 0.690 |
Why?
|
T-Lymphocytes, Regulatory | 11 | 2023 | 3116 | 0.680 |
Why?
|
Kidney | 12 | 2022 | 7058 | 0.670 |
Why?
|
Fetal Macrosomia | 1 | 2020 | 138 | 0.670 |
Why?
|
Apoptosis | 12 | 2023 | 9527 | 0.670 |
Why?
|
Cell Extracts | 1 | 2020 | 135 | 0.670 |
Why?
|
Diabetic Ketoacidosis | 1 | 2023 | 257 | 0.670 |
Why?
|
Diabetic Neuropathies | 2 | 2022 | 410 | 0.670 |
Why?
|
CD8-Positive T-Lymphocytes | 9 | 2024 | 4651 | 0.660 |
Why?
|
Diabetes Complications | 4 | 2015 | 1320 | 0.650 |
Why?
|
Organ Transplantation | 3 | 2022 | 1178 | 0.650 |
Why?
|
MicroRNAs | 4 | 2024 | 3811 | 0.650 |
Why?
|
Immunosuppressive Agents | 14 | 2018 | 4207 | 0.640 |
Why?
|
Inflammation | 12 | 2024 | 10868 | 0.630 |
Why?
|
Diabetic Angiopathies | 6 | 2012 | 806 | 0.630 |
Why?
|
Sodium-Glucose Transport Proteins | 1 | 2018 | 13 | 0.620 |
Why?
|
Kidney Diseases | 4 | 2015 | 2100 | 0.600 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 2020 | 287 | 0.600 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.600 |
Why?
|
Hypoglycemia | 2 | 2023 | 895 | 0.570 |
Why?
|
Ubiquinone | 1 | 2018 | 183 | 0.570 |
Why?
|
Hemostasis | 2 | 2013 | 468 | 0.570 |
Why?
|
Signal Transduction | 16 | 2023 | 23653 | 0.550 |
Why?
|
Complement Inactivating Agents | 1 | 2017 | 53 | 0.550 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2020 | 317 | 0.550 |
Why?
|
Chemokine CXCL12 | 4 | 2022 | 457 | 0.540 |
Why?
|
Transplantation Tolerance | 5 | 2021 | 633 | 0.540 |
Why?
|
Phosphates | 2 | 2012 | 765 | 0.530 |
Why?
|
Th17 Cells | 3 | 2018 | 791 | 0.530 |
Why?
|
C-Peptide | 11 | 2019 | 443 | 0.510 |
Why?
|
Membrane Proteins | 5 | 2022 | 7885 | 0.510 |
Why?
|
Italy | 4 | 2021 | 856 | 0.500 |
Why?
|
Anti-Inflammatory Agents | 3 | 2023 | 1811 | 0.490 |
Why?
|
Immunologic Memory | 2 | 2021 | 1378 | 0.490 |
Why?
|
B-Lymphocytes | 9 | 2019 | 4794 | 0.490 |
Why?
|
Lymphocyte Activation | 8 | 2021 | 5505 | 0.480 |
Why?
|
Triglycerides | 4 | 2021 | 2464 | 0.480 |
Why?
|
Pancreatitis, Chronic | 1 | 2017 | 282 | 0.470 |
Why?
|
Wound Healing | 2 | 2020 | 2815 | 0.470 |
Why?
|
Embryonic Stem Cells | 2 | 2020 | 1251 | 0.470 |
Why?
|
Cholesterol, HDL | 1 | 2021 | 1820 | 0.460 |
Why?
|
T-Lymphocytes | 10 | 2024 | 10276 | 0.460 |
Why?
|
Lymph Nodes | 8 | 2022 | 3473 | 0.460 |
Why?
|
Renal Dialysis | 3 | 2021 | 1789 | 0.460 |
Why?
|
Transplantation, Heterotopic | 2 | 2018 | 175 | 0.450 |
Why?
|
Receptors, Purinergic | 1 | 2014 | 66 | 0.440 |
Why?
|
Recombinant Fusion Proteins | 2 | 2020 | 3744 | 0.440 |
Why?
|
Proteome | 2 | 2020 | 1891 | 0.440 |
Why?
|
Receptors, Purinergic P2 | 1 | 2014 | 152 | 0.430 |
Why?
|
Extracellular Fluid | 1 | 2014 | 165 | 0.430 |
Why?
|
Communicable Diseases | 1 | 2021 | 873 | 0.430 |
Why?
|
Immune Tolerance | 4 | 2021 | 2323 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3118 | 0.410 |
Why?
|
Homeostasis | 2 | 2022 | 3347 | 0.410 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15661 | 0.410 |
Why?
|
Mice, Transgenic | 11 | 2022 | 9565 | 0.410 |
Why?
|
Immunologic Factors | 4 | 2019 | 1597 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3241 | 0.400 |
Why?
|
Immunotherapy | 3 | 2022 | 4756 | 0.400 |
Why?
|
Hematopoiesis | 1 | 2021 | 2059 | 0.400 |
Why?
|
Bone Marrow Cells | 6 | 2015 | 2414 | 0.400 |
Why?
|
Transplantation Immunology | 1 | 2014 | 537 | 0.390 |
Why?
|
Receptors, Interleukin-21 | 1 | 2011 | 32 | 0.390 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2021 | 4413 | 0.380 |
Why?
|
Male | 81 | 2024 | 365203 | 0.380 |
Why?
|
Antilymphocyte Serum | 3 | 2013 | 492 | 0.380 |
Why?
|
Cholesterol, LDL | 1 | 2021 | 2403 | 0.370 |
Why?
|
Glucagon-Like Peptide 1 | 4 | 2023 | 374 | 0.370 |
Why?
|
Insulin Infusion Systems | 2 | 2023 | 221 | 0.370 |
Why?
|
Valine | 1 | 2012 | 410 | 0.370 |
Why?
|
Diabetes, Gestational | 1 | 2020 | 1263 | 0.360 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 3 | 2010 | 381 | 0.350 |
Why?
|
Hepatitis C, Chronic | 1 | 2018 | 1033 | 0.350 |
Why?
|
Mesenchymal Stem Cells | 5 | 2015 | 1672 | 0.350 |
Why?
|
Proteomics | 6 | 2022 | 3914 | 0.350 |
Why?
|
Gene Expression Regulation | 4 | 2022 | 11932 | 0.340 |
Why?
|
Immunoconjugates | 3 | 2013 | 976 | 0.330 |
Why?
|
Middle Aged | 60 | 2024 | 223737 | 0.330 |
Why?
|
Aspirin | 1 | 2021 | 3135 | 0.330 |
Why?
|
Female | 75 | 2024 | 397515 | 0.320 |
Why?
|
Insulin Resistance | 7 | 2021 | 3982 | 0.320 |
Why?
|
Interleukin-10 | 1 | 2014 | 1183 | 0.320 |
Why?
|
Oxidative Stress | 3 | 2017 | 3139 | 0.310 |
Why?
|
Glucose | 4 | 2023 | 4352 | 0.310 |
Why?
|
Neovascularization, Physiologic | 2 | 2017 | 1371 | 0.300 |
Why?
|
Obesity | 5 | 2022 | 13091 | 0.300 |
Why?
|
Adult | 59 | 2024 | 223851 | 0.300 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2015 | 1943 | 0.290 |
Why?
|
Up-Regulation | 5 | 2019 | 4148 | 0.290 |
Why?
|
Pancreatic Neoplasms | 3 | 2024 | 5443 | 0.290 |
Why?
|
Gastrointestinal Diseases | 1 | 2016 | 1204 | 0.290 |
Why?
|
Colon | 1 | 2015 | 1803 | 0.280 |
Why?
|
Gene Targeting | 1 | 2010 | 841 | 0.280 |
Why?
|
Metabolomics | 1 | 2017 | 1675 | 0.280 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2013 | 1141 | 0.280 |
Why?
|
Pandemics | 4 | 2022 | 8749 | 0.280 |
Why?
|
Receptors, CCR2 | 1 | 2008 | 216 | 0.280 |
Why?
|
Tetrazoles | 1 | 2012 | 923 | 0.270 |
Why?
|
Interleukins | 1 | 2011 | 796 | 0.270 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2012 | 3782 | 0.270 |
Why?
|
Blood Vessels | 1 | 2012 | 1110 | 0.270 |
Why?
|
Mice, Knockout | 12 | 2022 | 14484 | 0.260 |
Why?
|
Benzhydryl Compounds | 2 | 2023 | 944 | 0.260 |
Why?
|
Antiviral Agents | 1 | 2018 | 3070 | 0.260 |
Why?
|
Dendritic Cells | 7 | 2018 | 2748 | 0.260 |
Why?
|
Antibodies, Monoclonal | 7 | 2013 | 9264 | 0.260 |
Why?
|
Chemokines, CC | 1 | 2007 | 286 | 0.260 |
Why?
|
Disease Models, Animal | 11 | 2021 | 18354 | 0.260 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2012 | 1064 | 0.260 |
Why?
|
Anthropometry | 2 | 2021 | 1345 | 0.260 |
Why?
|
Reperfusion Injury | 2 | 2018 | 1036 | 0.260 |
Why?
|
Graft vs Host Disease | 2 | 2018 | 3048 | 0.250 |
Why?
|
Membrane Glycoproteins | 4 | 2021 | 3713 | 0.250 |
Why?
|
Creatinine | 3 | 2023 | 1917 | 0.250 |
Why?
|
Cohort Studies | 7 | 2023 | 41808 | 0.250 |
Why?
|
Transplantation, Autologous | 4 | 2015 | 2126 | 0.240 |
Why?
|
Immune System | 3 | 2022 | 800 | 0.240 |
Why?
|
Gastric Inhibitory Polypeptide | 2 | 2023 | 69 | 0.240 |
Why?
|
Peptides | 3 | 2014 | 4353 | 0.240 |
Why?
|
Lung | 3 | 2023 | 10099 | 0.240 |
Why?
|
Regeneration | 2 | 2011 | 1524 | 0.230 |
Why?
|
Cardiovascular Physiological Phenomena | 2 | 2005 | 241 | 0.230 |
Why?
|
Central Nervous System | 1 | 2011 | 1346 | 0.230 |
Why?
|
Phenotype | 6 | 2022 | 16731 | 0.220 |
Why?
|
Endothelium, Vascular | 4 | 2020 | 4428 | 0.220 |
Why?
|
Glomerular Filtration Rate | 3 | 2023 | 2228 | 0.220 |
Why?
|
Fetal Blood | 1 | 2010 | 1361 | 0.210 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2024 | 89 | 0.210 |
Why?
|
Mycophenolic Acid | 2 | 2004 | 348 | 0.210 |
Why?
|
Pancreas | 4 | 2023 | 1700 | 0.210 |
Why?
|
Receptors, Interleukin-8A | 2 | 2021 | 47 | 0.210 |
Why?
|
HLA-DR3 Antigen | 1 | 2022 | 24 | 0.210 |
Why?
|
Treatment Outcome | 15 | 2024 | 65480 | 0.210 |
Why?
|
Alum Compounds | 1 | 2022 | 35 | 0.210 |
Why?
|
Receptors, Chemokine | 1 | 2006 | 652 | 0.210 |
Why?
|
Cell Proliferation | 6 | 2024 | 10486 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 478 | 0.210 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 440 | 0.210 |
Why?
|
Pursuit, Smooth | 1 | 2022 | 39 | 0.200 |
Why?
|
Body Weight | 2 | 2023 | 4628 | 0.200 |
Why?
|
Prediabetic State | 1 | 2008 | 548 | 0.200 |
Why?
|
Homocysteine | 3 | 2005 | 637 | 0.200 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2004 | 637 | 0.200 |
Why?
|
Melatonin | 2 | 1999 | 670 | 0.200 |
Why?
|
Respiratory Tract Fistula | 1 | 2002 | 25 | 0.200 |
Why?
|
Amino Acid Transport System X-AG | 1 | 2022 | 39 | 0.200 |
Why?
|
Proinsulin | 1 | 2022 | 135 | 0.200 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2022 | 89 | 0.200 |
Why?
|
Case-Control Studies | 8 | 2021 | 22296 | 0.200 |
Why?
|
Endothelial Cells | 2 | 2012 | 3592 | 0.190 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2059 | 0.190 |
Why?
|
Embolism, Paradoxical | 1 | 2002 | 55 | 0.190 |
Why?
|
Transplantation, Isogeneic | 2 | 2013 | 249 | 0.190 |
Why?
|
Retrospective Studies | 18 | 2024 | 81903 | 0.190 |
Why?
|
Electrocardiography | 4 | 2004 | 6413 | 0.190 |
Why?
|
Sexual Behavior | 1 | 2011 | 2200 | 0.190 |
Why?
|
Fructosamine | 1 | 2021 | 14 | 0.190 |
Why?
|
Receptors, Leptin | 2 | 2022 | 352 | 0.190 |
Why?
|
Receptors, Interleukin-8B | 1 | 2021 | 58 | 0.190 |
Why?
|
Glutamic Acid | 2 | 2024 | 1191 | 0.180 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2027 | 0.180 |
Why?
|
Hydrochlorothiazide | 1 | 2021 | 95 | 0.180 |
Why?
|
Flow Cytometry | 8 | 2019 | 5906 | 0.180 |
Why?
|
Apyrase | 1 | 2023 | 376 | 0.180 |
Why?
|
Albuminuria | 2 | 2022 | 658 | 0.180 |
Why?
|
Flour | 1 | 2020 | 22 | 0.180 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 3 | 2021 | 306 | 0.180 |
Why?
|
Saccades | 1 | 2022 | 235 | 0.180 |
Why?
|
Skin | 3 | 2010 | 4506 | 0.180 |
Why?
|
Neoplasms | 5 | 2024 | 22389 | 0.180 |
Why?
|
Intracranial Embolism | 1 | 2002 | 189 | 0.180 |
Why?
|
Fistula | 1 | 2002 | 213 | 0.170 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 299 | 0.170 |
Why?
|
Bone Marrow Transplantation | 3 | 2015 | 2709 | 0.170 |
Why?
|
Arteriosclerosis | 2 | 2003 | 1056 | 0.170 |
Why?
|
Mice, SCID | 3 | 2017 | 2631 | 0.170 |
Why?
|
Myocardial Reperfusion Injury | 3 | 2018 | 484 | 0.170 |
Why?
|
Parasites | 1 | 2022 | 160 | 0.170 |
Why?
|
Heart Neoplasms | 2 | 2001 | 374 | 0.170 |
Why?
|
Cells, Cultured | 4 | 2022 | 19023 | 0.170 |
Why?
|
Aged | 24 | 2024 | 171786 | 0.170 |
Why?
|
Duodenum | 2 | 2019 | 495 | 0.170 |
Why?
|
Ureteral Obstruction | 1 | 2021 | 297 | 0.170 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 622 | 0.170 |
Why?
|
Immunophenotyping | 2 | 2021 | 1866 | 0.170 |
Why?
|
Macrophages | 3 | 2021 | 5801 | 0.170 |
Why?
|
Antigens, CD | 3 | 2023 | 4032 | 0.170 |
Why?
|
Diastole | 3 | 2000 | 785 | 0.170 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2021 | 619 | 0.160 |
Why?
|
Cell Differentiation | 6 | 2020 | 11684 | 0.160 |
Why?
|
Cell Movement | 5 | 2018 | 5216 | 0.160 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2020 | 856 | 0.160 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2020 | 91 | 0.160 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2004 | 1141 | 0.160 |
Why?
|
Clinical Trials as Topic | 5 | 2019 | 8055 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2022 | 4592 | 0.160 |
Why?
|
Verapamil | 1 | 2019 | 242 | 0.160 |
Why?
|
Immunity, Innate | 2 | 2022 | 3080 | 0.160 |
Why?
|
Immune System Diseases | 1 | 2021 | 253 | 0.160 |
Why?
|
Immunoblotting | 1 | 2022 | 1647 | 0.150 |
Why?
|
Interleukin-6 | 2 | 2019 | 3232 | 0.150 |
Why?
|
Angina Pectoris | 2 | 2000 | 957 | 0.150 |
Why?
|
Dry Eye Syndromes | 1 | 2023 | 384 | 0.150 |
Why?
|
Caloric Restriction | 1 | 2021 | 301 | 0.150 |
Why?
|
Time Factors | 17 | 2024 | 40261 | 0.150 |
Why?
|
Crohn Disease | 2 | 2021 | 2294 | 0.150 |
Why?
|
3T3 Cells | 1 | 2020 | 1085 | 0.150 |
Why?
|
Stem Cell Niche | 1 | 2021 | 347 | 0.150 |
Why?
|
Th1 Cells | 2 | 2014 | 1042 | 0.150 |
Why?
|
Oxygen | 1 | 2010 | 4272 | 0.150 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2011 | 305 | 0.150 |
Why?
|
Splenic Artery | 1 | 2018 | 58 | 0.150 |
Why?
|
Fibrosis | 3 | 2021 | 2080 | 0.150 |
Why?
|
Serum Albumin | 1 | 2021 | 677 | 0.150 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2005 | 2145 | 0.150 |
Why?
|
Retinal Artery | 2 | 2010 | 109 | 0.140 |
Why?
|
Diet, Reducing | 1 | 2021 | 487 | 0.140 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2010 | 660 | 0.140 |
Why?
|
Proteinuria | 3 | 2015 | 610 | 0.140 |
Why?
|
Immunity | 2 | 2022 | 1003 | 0.140 |
Why?
|
Mutation | 2 | 2018 | 30266 | 0.140 |
Why?
|
Probiotics | 1 | 2020 | 383 | 0.140 |
Why?
|
Legionnaires' Disease | 1 | 1996 | 50 | 0.130 |
Why?
|
Fatty Liver | 2 | 2015 | 810 | 0.130 |
Why?
|
Stromal Cells | 1 | 2022 | 1337 | 0.130 |
Why?
|
Proctocolectomy, Restorative | 1 | 2018 | 191 | 0.130 |
Why?
|
Aortic Diseases | 1 | 2002 | 741 | 0.130 |
Why?
|
Benchmarking | 1 | 2022 | 1059 | 0.130 |
Why?
|
Interleukin-1beta | 1 | 2021 | 1026 | 0.130 |
Why?
|
Fas Ligand Protein | 2 | 2007 | 217 | 0.130 |
Why?
|
Angina, Unstable | 1 | 2000 | 893 | 0.130 |
Why?
|
Digestive System Surgical Procedures | 1 | 2021 | 584 | 0.130 |
Why?
|
Adipose Tissue | 2 | 2017 | 3335 | 0.130 |
Why?
|
Receptors, Purinergic P2X | 1 | 2015 | 9 | 0.120 |
Why?
|
Aneurysm | 1 | 2018 | 343 | 0.120 |
Why?
|
Arginine | 3 | 2009 | 932 | 0.120 |
Why?
|
Suramin | 1 | 2014 | 34 | 0.120 |
Why?
|
Pancreas, Exocrine | 1 | 2014 | 48 | 0.120 |
Why?
|
Lung Diseases | 2 | 2021 | 1944 | 0.120 |
Why?
|
Risk Factors | 9 | 2024 | 74976 | 0.120 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2015 | 510 | 0.120 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 994 | 0.120 |
Why?
|
Venoms | 1 | 2014 | 94 | 0.120 |
Why?
|
Brain Ischemia | 2 | 1999 | 3008 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1266 | 0.110 |
Why?
|
Biopsy | 4 | 2015 | 6805 | 0.110 |
Why?
|
Spleen | 3 | 2015 | 2294 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2004 | 2911 | 0.110 |
Why?
|
Myocardium | 3 | 2004 | 4790 | 0.110 |
Why?
|
STAT1 Transcription Factor | 1 | 2015 | 343 | 0.110 |
Why?
|
Complement System Proteins | 1 | 2017 | 738 | 0.110 |
Why?
|
Heart | 3 | 2004 | 4447 | 0.110 |
Why?
|
Intra-Abdominal Fat | 1 | 2019 | 625 | 0.110 |
Why?
|
Blood Platelets | 3 | 2013 | 2479 | 0.110 |
Why?
|
Quality of Life | 5 | 2022 | 13510 | 0.110 |
Why?
|
Fibroblasts | 2 | 2022 | 4179 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2024 | 2884 | 0.110 |
Why?
|
rho-Associated Kinases | 1 | 2015 | 285 | 0.110 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 26395 | 0.110 |
Why?
|
Age of Onset | 1 | 2020 | 3346 | 0.110 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 737 | 0.110 |
Why?
|
Blood Pressure | 5 | 2010 | 8544 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.100 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 997 | 0.100 |
Why?
|
Embolization, Therapeutic | 2 | 2018 | 1410 | 0.100 |
Why?
|
Pancreatic Ducts | 1 | 2014 | 330 | 0.100 |
Why?
|
Forkhead Transcription Factors | 2 | 2011 | 1625 | 0.100 |
Why?
|
Autoantigens | 2 | 2014 | 891 | 0.100 |
Why?
|
Immunocompetence | 1 | 2012 | 138 | 0.100 |
Why?
|
Lipid Metabolism | 1 | 2021 | 1904 | 0.100 |
Why?
|
Cell Division | 3 | 2010 | 4478 | 0.100 |
Why?
|
STAT3 Transcription Factor | 2 | 2015 | 874 | 0.100 |
Why?
|
Vaccination | 2 | 2022 | 3438 | 0.100 |
Why?
|
Myocardial Infarction | 4 | 2004 | 11521 | 0.100 |
Why?
|
Papio | 3 | 2019 | 672 | 0.100 |
Why?
|
Hypertension | 3 | 2020 | 8617 | 0.100 |
Why?
|
Laparoscopy | 2 | 2021 | 2055 | 0.100 |
Why?
|
Granzymes | 1 | 2013 | 278 | 0.100 |
Why?
|
Comorbidity | 2 | 2020 | 10592 | 0.100 |
Why?
|
Serpins | 1 | 2013 | 246 | 0.100 |
Why?
|
Cesarean Section | 1 | 2020 | 1426 | 0.100 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 2 | 2005 | 480 | 0.100 |
Why?
|
Metformin | 1 | 2019 | 909 | 0.100 |
Why?
|
Folic Acid | 1 | 1998 | 1338 | 0.090 |
Why?
|
Hepacivirus | 1 | 2018 | 1344 | 0.090 |
Why?
|
Gene Expression | 5 | 2019 | 7603 | 0.090 |
Why?
|
Calcitriol | 2 | 2003 | 303 | 0.090 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3450 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3215 | 0.090 |
Why?
|
Maternal-Fetal Exchange | 1 | 2013 | 456 | 0.090 |
Why?
|
bcl-Associated Death Protein | 1 | 2010 | 102 | 0.090 |
Why?
|
Off-Label Use | 1 | 2012 | 185 | 0.090 |
Why?
|
Antigen-Presenting Cells | 2 | 2013 | 962 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 3 | 2013 | 1813 | 0.090 |
Why?
|
Penis | 1 | 2011 | 210 | 0.090 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2011 | 306 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1197 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5801 | 0.090 |
Why?
|
Isoantigens | 1 | 2012 | 562 | 0.090 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2013 | 336 | 0.090 |
Why?
|
Survival Analysis | 8 | 2014 | 10115 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2024 | 2460 | 0.090 |
Why?
|
Quinoxalines | 1 | 2012 | 297 | 0.080 |
Why?
|
Sirolimus | 3 | 2013 | 1540 | 0.080 |
Why?
|
Mice, Inbred DBA | 1 | 2010 | 624 | 0.080 |
Why?
|
Benzylamines | 1 | 2010 | 251 | 0.080 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2634 | 0.080 |
Why?
|
Heterocyclic Compounds | 1 | 2010 | 245 | 0.080 |
Why?
|
bcl-2-Associated X Protein | 1 | 2010 | 282 | 0.080 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2010 | 225 | 0.080 |
Why?
|
Microdissection | 1 | 2009 | 150 | 0.080 |
Why?
|
Lymphocytes | 2 | 2009 | 2614 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2014 | 1340 | 0.080 |
Why?
|
Cell Line | 2 | 2022 | 15604 | 0.080 |
Why?
|
Antioxidants | 1 | 2017 | 1673 | 0.080 |
Why?
|
Child | 8 | 2024 | 80960 | 0.080 |
Why?
|
Thiazolidinediones | 1 | 2012 | 461 | 0.080 |
Why?
|
Adiposity | 1 | 2019 | 1895 | 0.080 |
Why?
|
Postoperative Complications | 10 | 2024 | 15889 | 0.080 |
Why?
|
Skin Transplantation | 2 | 2013 | 1097 | 0.080 |
Why?
|
Myocarditis | 1 | 1996 | 803 | 0.080 |
Why?
|
Ovalbumin | 1 | 2010 | 677 | 0.080 |
Why?
|
Carcinoma, Papillary | 2 | 2004 | 793 | 0.080 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2227 | 0.080 |
Why?
|
Remission Induction | 1 | 2014 | 2408 | 0.080 |
Why?
|
Follow-Up Studies | 11 | 2024 | 39394 | 0.080 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4568 | 0.080 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 505 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9621 | 0.080 |
Why?
|
Serine Endopeptidases | 1 | 2013 | 1027 | 0.070 |
Why?
|
Ultrasonography | 4 | 2021 | 6002 | 0.070 |
Why?
|
Erectile Dysfunction | 1 | 2011 | 445 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4356 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2001 | 4064 | 0.070 |
Why?
|
Metabolism, Inborn Errors | 1 | 2010 | 292 | 0.070 |
Why?
|
Endocrine System Diseases | 1 | 2010 | 250 | 0.070 |
Why?
|
Annexin A5 | 1 | 2007 | 104 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2010 | 3813 | 0.070 |
Why?
|
Selectins | 1 | 2007 | 101 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4432 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4045 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2021 | 2442 | 0.070 |
Why?
|
Chemokine CCL21 | 1 | 2007 | 49 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1911 | 0.070 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 892 | 0.070 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 1418 | 0.070 |
Why?
|
Integrin beta3 | 1 | 2007 | 120 | 0.070 |
Why?
|
Survival Rate | 3 | 2014 | 12873 | 0.070 |
Why?
|
Brain | 1 | 2013 | 27453 | 0.070 |
Why?
|
Stents | 1 | 2018 | 3200 | 0.070 |
Why?
|
Retinal Vein | 1 | 2006 | 47 | 0.070 |
Why?
|
Antigens, CD34 | 1 | 2008 | 656 | 0.070 |
Why?
|
Cell Death | 1 | 2011 | 1682 | 0.070 |
Why?
|
Echocardiography, Doppler | 4 | 1997 | 898 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1936 | 0.060 |
Why?
|
Adolescent | 7 | 2024 | 89244 | 0.060 |
Why?
|
Glycolysis | 1 | 2010 | 838 | 0.060 |
Why?
|
Antibodies | 2 | 2011 | 2422 | 0.060 |
Why?
|
Disease Progression | 4 | 2022 | 13674 | 0.060 |
Why?
|
Body Mass Index | 3 | 2021 | 13055 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2007 | 896 | 0.060 |
Why?
|
Tissue Donors | 4 | 2009 | 2382 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2017 | 3859 | 0.060 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2004 | 46 | 0.060 |
Why?
|
Receptors, CXCR3 | 1 | 2006 | 240 | 0.060 |
Why?
|
Erythrocytes | 2 | 2005 | 2421 | 0.060 |
Why?
|
Lung Transplantation | 1 | 2014 | 1309 | 0.060 |
Why?
|
Platelet Membrane Glycoprotein IIb | 1 | 2004 | 51 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12095 | 0.060 |
Why?
|
Cyclosporine | 2 | 2004 | 777 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2007 | 684 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2015 | 3044 | 0.060 |
Why?
|
Prothrombin Time | 1 | 2004 | 117 | 0.060 |
Why?
|
Thallium Radioisotopes | 1 | 2004 | 139 | 0.060 |
Why?
|
Atherosclerosis | 1 | 2020 | 3431 | 0.060 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2004 | 147 | 0.060 |
Why?
|
Receptors, Thrombin | 1 | 2004 | 130 | 0.060 |
Why?
|
Atrial Natriuretic Factor | 1 | 2005 | 350 | 0.060 |
Why?
|
Leptin | 2 | 2019 | 1597 | 0.060 |
Why?
|
Transforming Growth Factor beta | 2 | 2022 | 2004 | 0.060 |
Why?
|
Swine | 1 | 2014 | 5997 | 0.060 |
Why?
|
Transcription Factors | 1 | 2024 | 12174 | 0.060 |
Why?
|
Interleukin-4 | 1 | 2008 | 1157 | 0.060 |
Why?
|
Chronic Disease | 3 | 2012 | 9384 | 0.060 |
Why?
|
Prognosis | 4 | 2020 | 30046 | 0.060 |
Why?
|
Survivors | 2 | 2012 | 2383 | 0.060 |
Why?
|
Coronary Artery Bypass | 3 | 1998 | 2194 | 0.060 |
Why?
|
Interleukin-18 | 1 | 2005 | 251 | 0.060 |
Why?
|
Receptor, PAR-1 | 1 | 2004 | 109 | 0.060 |
Why?
|
Partial Thromboplastin Time | 1 | 2004 | 204 | 0.060 |
Why?
|
Placenta | 1 | 2013 | 1725 | 0.060 |
Why?
|
Receptors, Glucagon | 1 | 2023 | 90 | 0.050 |
Why?
|
Smoking | 1 | 2020 | 9094 | 0.050 |
Why?
|
Hydrocortisone | 2 | 2023 | 1841 | 0.050 |
Why?
|
Down-Regulation | 2 | 2015 | 2942 | 0.050 |
Why?
|
Hypertrophy | 1 | 2005 | 562 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2004 | 515 | 0.050 |
Why?
|
Administration, Rectal | 1 | 2022 | 69 | 0.050 |
Why?
|
Antithrombin III | 1 | 2003 | 128 | 0.050 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2019 | 1356 | 0.050 |
Why?
|
Insulin Antagonists | 1 | 2002 | 17 | 0.050 |
Why?
|
Protein C | 1 | 2003 | 134 | 0.050 |
Why?
|
Genes, Reporter | 1 | 2007 | 1524 | 0.050 |
Why?
|
Interferon-gamma | 3 | 2018 | 3163 | 0.050 |
Why?
|
Fetal Heart | 1 | 2004 | 281 | 0.050 |
Why?
|
Incretins | 1 | 2023 | 100 | 0.050 |
Why?
|
Infusions, Intravenous | 2 | 2019 | 2231 | 0.050 |
Why?
|
5'-Nucleotidase | 1 | 2023 | 164 | 0.050 |
Why?
|
Laser Therapy | 1 | 2009 | 1110 | 0.050 |
Why?
|
Phosphorylation | 4 | 2012 | 8317 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 36854 | 0.050 |
Why?
|
Hemodynamics | 2 | 2011 | 4199 | 0.050 |
Why?
|
Dendritic Cells, Follicular | 1 | 2022 | 50 | 0.050 |
Why?
|
Urinary Diversion | 1 | 2002 | 137 | 0.050 |
Why?
|
Radionuclide Imaging | 3 | 2001 | 1998 | 0.050 |
Why?
|
Venules | 1 | 2022 | 161 | 0.050 |
Why?
|
Calcium | 2 | 2005 | 5792 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 911 | 0.050 |
Why?
|
Tears | 1 | 2023 | 253 | 0.050 |
Why?
|
Proline | 1 | 2003 | 455 | 0.050 |
Why?
|
Glucose Tolerance Test | 1 | 2024 | 1183 | 0.050 |
Why?
|
Cholesterol | 2 | 2007 | 2913 | 0.050 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1626 | 0.040 |
Why?
|
Diabetic Retinopathy | 2 | 2010 | 1299 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2006 | 14752 | 0.040 |
Why?
|
Mesentery | 1 | 2021 | 202 | 0.040 |
Why?
|
Albumins | 1 | 2003 | 577 | 0.040 |
Why?
|
Aneurysm, False | 1 | 2003 | 263 | 0.040 |
Why?
|
Pregnancy | 2 | 2020 | 30265 | 0.040 |
Why?
|
STAT5 Transcription Factor | 1 | 2021 | 268 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10847 | 0.040 |
Why?
|
Probability | 1 | 2006 | 2483 | 0.040 |
Why?
|
Reference Values | 2 | 2006 | 4940 | 0.040 |
Why?
|
Fermentation | 1 | 2020 | 143 | 0.040 |
Why?
|
Thyroid Neoplasms | 2 | 2004 | 2360 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2020 | 26428 | 0.040 |
Why?
|
Carbon Monoxide | 1 | 2023 | 559 | 0.040 |
Why?
|
Treatment Failure | 2 | 2004 | 2664 | 0.040 |
Why?
|
Pilot Projects | 1 | 2013 | 8748 | 0.040 |
Why?
|
Arteriovenous Fistula | 1 | 2003 | 320 | 0.040 |
Why?
|
Vasodilation | 1 | 2004 | 967 | 0.040 |
Why?
|
Hyaluronic Acid | 1 | 2023 | 488 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2011 | 1891 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2010 | 1665 | 0.040 |
Why?
|
Prevalence | 3 | 2024 | 15879 | 0.040 |
Why?
|
Urologic Diseases | 1 | 2002 | 247 | 0.040 |
Why?
|
Glucose Clamp Technique | 1 | 2019 | 263 | 0.040 |
Why?
|
Endothelium | 1 | 2022 | 768 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2006 | 6236 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2024 | 621 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 2021 | 333 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3952 | 0.040 |
Why?
|
Blood Flow Velocity | 3 | 2010 | 1376 | 0.040 |
Why?
|
Stomach | 1 | 2003 | 702 | 0.040 |
Why?
|
NF-kappa B | 3 | 2015 | 2492 | 0.040 |
Why?
|
Lymphotoxin beta Receptor | 1 | 2018 | 26 | 0.040 |
Why?
|
Renin-Angiotensin System | 1 | 2003 | 736 | 0.040 |
Why?
|
Cell Transdifferentiation | 1 | 2019 | 187 | 0.040 |
Why?
|
Cardioplegic Solutions | 1 | 1998 | 123 | 0.040 |
Why?
|
Incidence | 1 | 2017 | 21547 | 0.040 |
Why?
|
Chemokine CXCL10 | 1 | 2019 | 311 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2004 | 1161 | 0.040 |
Why?
|
Protein Transport | 1 | 2024 | 1956 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2010 | 1907 | 0.040 |
Why?
|
Solubility | 1 | 2000 | 1087 | 0.040 |
Why?
|
Ventricular Function, Left | 3 | 2001 | 3941 | 0.040 |
Why?
|
Thrombosis | 2 | 2003 | 2956 | 0.040 |
Why?
|
Sodium | 1 | 2003 | 1597 | 0.040 |
Why?
|
Periodicity | 1 | 1999 | 348 | 0.040 |
Why?
|
Adoptive Transfer | 2 | 2013 | 824 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1408 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11116 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2005 | 1126 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2010 | 2517 | 0.040 |
Why?
|
Lymphatic Vessels | 1 | 2022 | 356 | 0.040 |
Why?
|
Gated Blood-Pool Imaging | 1 | 1997 | 44 | 0.040 |
Why?
|
Hormones | 1 | 2021 | 870 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 999 | 0.040 |
Why?
|
Uveitis | 1 | 2021 | 398 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2019 | 577 | 0.030 |
Why?
|
Heart Arrest, Induced | 1 | 1998 | 361 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2022 | 59739 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 60131 | 0.030 |
Why?
|
Indium Radioisotopes | 1 | 1996 | 116 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2019 | 588 | 0.030 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 1998 | 252 | 0.030 |
Why?
|
Suction | 1 | 2017 | 268 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2005 | 1751 | 0.030 |
Why?
|
Legionella pneumophila | 1 | 1996 | 50 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2020 | 1048 | 0.030 |
Why?
|
Neuroglia | 1 | 2022 | 960 | 0.030 |
Why?
|
Fasting | 2 | 2019 | 1610 | 0.030 |
Why?
|
RNA | 1 | 2006 | 2727 | 0.030 |
Why?
|
Methionine | 1 | 1998 | 573 | 0.030 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1996 | 424 | 0.030 |
Why?
|
Lung Neoplasms | 1 | 2000 | 13594 | 0.030 |
Why?
|
Exercise Test | 1 | 2023 | 2187 | 0.030 |
Why?
|
Heart Failure | 1 | 2000 | 11879 | 0.030 |
Why?
|
Gestational Age | 1 | 2004 | 3621 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2010 | 1439 | 0.030 |
Why?
|
Pancreatic Function Tests | 1 | 2015 | 69 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 855 | 0.030 |
Why?
|
Monocytes | 1 | 2004 | 2603 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2474 | 0.030 |
Why?
|
Liver | 2 | 2015 | 7578 | 0.030 |
Why?
|
Myosins | 1 | 1996 | 408 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 1997 | 2171 | 0.030 |
Why?
|
Myosin Heavy Chains | 1 | 1996 | 404 | 0.030 |
Why?
|
Amylases | 1 | 2014 | 171 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2023 | 2149 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2005 | 2905 | 0.030 |
Why?
|
Ultrasonography, Doppler, Color | 2 | 2006 | 234 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3441 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2005 | 1300 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2022 | 1739 | 0.030 |
Why?
|
Rheumatic Diseases | 1 | 2021 | 659 | 0.030 |
Why?
|
Feces | 1 | 2020 | 1510 | 0.030 |
Why?
|
Troponin T | 1 | 1998 | 787 | 0.030 |
Why?
|
Blood Proteins | 1 | 2019 | 1191 | 0.030 |
Why?
|
Litter Size | 1 | 2013 | 49 | 0.030 |
Why?
|
Embryo Loss | 1 | 2013 | 55 | 0.030 |
Why?
|
Histocompatibility | 1 | 2014 | 321 | 0.030 |
Why?
|
Heart Ventricles | 1 | 2005 | 3840 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2120 | 0.030 |
Why?
|
Adiponectin | 1 | 2019 | 1117 | 0.030 |
Why?
|
Prospective Studies | 4 | 2021 | 54962 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15951 | 0.030 |
Why?
|
Skin Diseases | 1 | 2021 | 1085 | 0.030 |
Why?
|
Mice, Inbred CBA | 1 | 2013 | 438 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2014 | 628 | 0.030 |
Why?
|
Choroid | 1 | 2015 | 363 | 0.030 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 117 | 0.030 |
Why?
|
Regression Analysis | 4 | 2005 | 6346 | 0.020 |
Why?
|
Cell Polarity | 1 | 2015 | 639 | 0.020 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2011 | 126 | 0.020 |
Why?
|
Killer Cells, Natural | 2 | 2013 | 2211 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2013 | 472 | 0.020 |
Why?
|
Choroidal Neovascularization | 1 | 2015 | 364 | 0.020 |
Why?
|
Hyperplasia | 1 | 2014 | 1154 | 0.020 |
Why?
|
Tacrolimus | 2 | 2007 | 750 | 0.020 |
Why?
|
Health Care Rationing | 1 | 2014 | 435 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2015 | 906 | 0.020 |
Why?
|
Rats | 2 | 2021 | 23786 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2021 | 9549 | 0.020 |
Why?
|
Antibodies, Bacterial | 1 | 1996 | 1478 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1890 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1996 | 1560 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2003 | 13698 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5323 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42683 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2216 | 0.020 |
Why?
|
Growth Disorders | 1 | 2014 | 635 | 0.020 |
Why?
|
Streptozocin | 1 | 2009 | 190 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 1996 | 1176 | 0.020 |
Why?
|
Malondialdehyde | 1 | 2009 | 113 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2431 | 0.020 |
Why?
|
Recurrence | 1 | 2021 | 8513 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2001 | 13021 | 0.020 |
Why?
|
HLA-D Antigens | 1 | 2008 | 130 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 1998 | 2139 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 2009 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2009 | 1163 | 0.020 |
Why?
|
Reoperation | 1 | 2018 | 4342 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2015 | 14794 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2635 | 0.020 |
Why?
|
Macular Degeneration | 1 | 2015 | 1016 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1973 | 0.020 |
Why?
|
CD40 Ligand | 1 | 2009 | 528 | 0.020 |
Why?
|
Integrin alpha4beta1 | 1 | 2007 | 119 | 0.020 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2013 | 1363 | 0.020 |
Why?
|
Rabbits | 1 | 2013 | 4774 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12467 | 0.020 |
Why?
|
Antibody Formation | 1 | 2010 | 1393 | 0.020 |
Why?
|
Phosphorus Isotopes | 1 | 2005 | 125 | 0.020 |
Why?
|
Phosphocreatine | 1 | 2005 | 261 | 0.010 |
Why?
|
Isoantibodies | 1 | 2009 | 681 | 0.010 |
Why?
|
Actuarial Analysis | 1 | 2004 | 372 | 0.010 |
Why?
|
Hemoglobins, Abnormal | 1 | 2004 | 119 | 0.010 |
Why?
|
Electrophysiology | 1 | 2007 | 1266 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15471 | 0.010 |
Why?
|
Length of Stay | 1 | 2018 | 6526 | 0.010 |
Why?
|
Thiocarbamates | 1 | 2003 | 30 | 0.010 |
Why?
|
Peripheral Nerves | 1 | 2007 | 492 | 0.010 |
Why?
|
Renal Circulation | 1 | 2004 | 291 | 0.010 |
Why?
|
Renal Replacement Therapy | 1 | 2005 | 282 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2067 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 1667 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 18068 | 0.010 |
Why?
|
I-kappa B Proteins | 1 | 2003 | 210 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 379 | 0.010 |
Why?
|
Coronary Stenosis | 1 | 2007 | 802 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2010 | 2574 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1614 | 0.010 |
Why?
|
Microcirculation | 1 | 2006 | 1281 | 0.010 |
Why?
|
Vascular Resistance | 1 | 2004 | 939 | 0.010 |
Why?
|
Cadaver | 1 | 2005 | 1366 | 0.010 |
Why?
|
Cyclins | 1 | 2003 | 606 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10765 | 0.010 |
Why?
|
Living Donors | 1 | 2005 | 649 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2004 | 947 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2007 | 3102 | 0.010 |
Why?
|
Neck | 1 | 2004 | 736 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2001 | 20776 | 0.010 |
Why?
|
Gene Deletion | 1 | 2007 | 2674 | 0.010 |
Why?
|
Pancreaticoduodenectomy | 1 | 2003 | 516 | 0.010 |
Why?
|
Drainage | 1 | 2005 | 1184 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6512 | 0.010 |
Why?
|
Thyroidectomy | 1 | 2004 | 914 | 0.010 |
Why?
|
Recovery of Function | 1 | 2009 | 2990 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2004 | 1273 | 0.010 |
Why?
|
Infant | 1 | 2020 | 36556 | 0.010 |
Why?
|
Arteries | 1 | 2003 | 1126 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2002 | 1207 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 1246 | 0.010 |
Why?
|
HLA Antigens | 1 | 2003 | 1336 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2004 | 1434 | 0.010 |
Why?
|
Drug Resistance | 1 | 2003 | 1599 | 0.010 |
Why?
|
Immunoradiometric Assay | 1 | 1996 | 20 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2004 | 2916 | 0.010 |
Why?
|
Creatine Kinase | 1 | 1998 | 684 | 0.010 |
Why?
|
Morbidity | 1 | 2002 | 1757 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2003 | 1277 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8745 | 0.010 |
Why?
|
Postoperative Care | 1 | 2002 | 1481 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2005 | 2820 | 0.010 |
Why?
|
Cardiac Output, Low | 1 | 1996 | 192 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6131 | 0.010 |
Why?
|
Age Factors | 1 | 2011 | 18435 | 0.010 |
Why?
|
Cold Temperature | 1 | 1998 | 791 | 0.010 |
Why?
|
Systole | 1 | 1997 | 937 | 0.010 |
Why?
|
Isoenzymes | 1 | 1998 | 1687 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2003 | 2893 | 0.010 |
Why?
|
Cell Survival | 1 | 2002 | 5793 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2003 | 2960 | 0.010 |
Why?
|
Hot Temperature | 1 | 1998 | 1441 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3726 | 0.010 |
Why?
|
Cause of Death | 1 | 2001 | 3721 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1996 | 3438 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2004 | 12562 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2004 | 11262 | 0.010 |
Why?
|
Databases, Factual | 1 | 2004 | 8094 | 0.000 |
Why?
|
Proteins | 1 | 2003 | 6011 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2002 | 12806 | 0.000 |
Why?
|
Linear Models | 1 | 1997 | 5891 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2004 | 9442 | 0.000 |
Why?
|
Risk Assessment | 1 | 2004 | 24333 | 0.000 |
Why?
|
Stroke Volume | 1 | 1997 | 5622 | 0.000 |
Why?
|